Safety and Efficacy of Rivaroxaban as Extended-Phase Anticoagulation in Patients with Cancer and Venous Thromboembolism: A Preliminary Data Analysis from the Mac Project
Sign Up to like & getrecommendations! Published in 2022 at "Life"
DOI: 10.3390/life12111725
Abstract: Extended-phase anticoagulation with direct oral Xa inhibitors (OAXI) is suggested in patients with cancer-associated venous thromboembolism (CAT). We report on patients enrolled in the MAC (Monitoring AntiCoagulants) Project, given rivaroxaban as extended-phase anticoagulation after CAT.… read more here.
Keywords: patients cancer; venous thromboembolism; rivaroxaban extended; phase anticoagulation ... See more keywords